NEW YORK, March 8 (Reuters) – Billionaire investor Bill Ackman on Tuesday called embattled drug company Valeant Pharmaceuticals a “very valuable asset” but forecast that if the company’s situation…
The post UPDATE 1-Fund manager Ackman calls Valeant ‘very valuable asset’ appeared first on NASDAQ.